Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
11.80
+0.37 (3.24%)
Aug 22, 2025, 4:00 PM - Market closed
Elicio Therapeutics Market Cap
Elicio Therapeutics has a market cap or net worth of $192.62 million as of August 25, 2025. Its market cap has increased by 316.05% in one year.
Market Cap
192.62M
Enterprise Value
185.44M
1-Year Change
316.05%
Ranking
Category
Stock Price
$11.80
Market Cap Chart
Since June 2, 2023, Elicio Therapeutics's market cap has decreased from $312.21M to $192.62M, a decrease of -38.30%. That is a compound annual growth rate of -19.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 192.62M | 250.46% |
| Dec 31, 2024 | 54.96M | -31.39% |
| Dec 29, 2023 | 80.11M | -74.34% |
| Jun 2, 2023 | 312.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 638.90B |
| Johnson & Johnson | 431.79B |
| AbbVie | 372.04B |
| UnitedHealth Group | 278.42B |
| Novo Nordisk | 253.97B |
| AstraZeneca | 251.25B |
| Novartis AG | 246.51B |
| Abbott Laboratories | 230.77B |